Available in 10 markets
State Street® Health Care Select Sector SPDR® ETF
State Street® Health Care Select Sector SPDR® ETF is an exchange-traded fund (ETF) from SPDR, traded under the ticker XLV (ISIN US81369Y2090). In a single purchase you get a diversified basket of holdings rather than a stake in just one business. In plain terms it is about owning small slices of companies, so you share in their growth when they…
Opens the screener with this filter applied.
About this fund
What you own
The Health Care Select Sector Index index is the benchmark this fund aims to copy. By holding it, this fund gives you a stake in around 63 companies across Other in a single purchase.
How it works
The fund actually buys every share in the index it tracks (full replication).
Read more
Owning every holding keeps things transparent — what is in the index is what the fund actually owns. It can be a touch costlier to run for indexes with thousands of tiny positions, since the fund has to buy and maintain them all. There is no swap bank involved, so there is no extra “what if the partner fails” question to weigh.
Cost
The yearly running cost of the fund, shown as a % of your money. Lower is cheaper.
Read more
For example, a 0.20% fee works out at €0.20 a year for every €100 invested — that’s a generic illustration of the mechanic, not this fund’s own fee. It is skimmed quietly from inside the fund a little each day, so you never get a bill — but it drags on your return every year you hold. On a broad index ETF it is usually a small fraction of a percent; the gap between a cheap and a pricey fund looks tiny on day one but compounds over decades, which is why it is worth a glance.
Fund facts
Performance
Growth of $100 invested — the line starts at $100.
End-of-day prices, rebased to a common start so the shapes are comparable. Past performance does not predict future results.
Return, year by year
How bumpy has it been?
The bigger picture
What's inside
By sector ?
The 10 biggest holdings make up 61.2% of the fund — the rest is spread across roughly 53 more companies.
Top 10 holdings
| # | Company | Weight |
|---|---|---|
| 1 | ELI LILLY + CO | 16.2% |
| 2 | JOHNSON + JOHNSON | 10.7% |
| 3 | ABBVIE INC | 7.7% |
| 4 | UNITEDHEALTH GROUP INC | 6.5% |
| 5 | MERCK + CO. INC. | 5.3% |
| 6 | AMGEN INC | 3.4% |
| 7 | THERMO FISHER SCIENTIFIC INC | 3.3% |
| 8 | ABBOTT LABORATORIES | 2.8% |
| 9 | GILEAD SCIENCES INC | 2.7% |
| 10 | INTUITIVE SURGICAL INC | 2.6% |
Where to buy this fund
Set from your language & location — change it if it's wrong.
Where it trades
| Exchange | Ticker | Currency | |
|---|---|---|---|
| NYSE | XLV | USD | ★ Primary |
| EUR listings | |||
| Frankfurt | SD7C | EUR | |
| USD listings | |||
| B2 | XLVUSD | USD | |
| B3 | XLVN | USD | |
| B4 | XLVUSD | USD | |
| E1 | XLV | USD | |
| E1 | XLVGBP | USD | |
| E1 | XLVRUB | USD | |
| E1 | XLVUSD | USD | |
| EP | XLVUSD | USD | |
| EP | XLVRUB | USD | |
| EU | XLV | USD | |
| EU | XLVGBP | USD | |
| EU | XLVRUB | USD | |
| EU | XLVUSD | USD | |
| EZ | XLVUSD | USD | |
| EZ | XLVRUB | USD | |
| GH | SD7C | USD | |
| GI | SD7C | USD | |
| L1 | XLVN | USD | |
| L3 | XLVN | USD | |
| LA | SD7C | USD | |
| LU | SD7C | USD | |
| MF | XLV* | USD | |
| MM | XLV* | USD | |
| MU | XLV* | USD | |
| NYSE Arca | XLV | USD | |
| OC | XLV | USD | |
| PE | XLV | USD | |
| PO | XLVN | USD | |
| TH | SD7C | USD | |
| UA | XLV | USD | |
| UB | XLV | USD | |
| UC | XLV | USD | |
| UD | XLV | USD | |
| UF | XLV | USD | |
| UM | XLV | USD | |
| US | XLV | USD | |
| UT | XLV | USD | |
| UX | XLV | USD | |
| VF | XLV | USD | |
| VG | XLV | USD | |
| VJ | XLV | USD | |
| VK | XLV | USD | |
| VP | XLV | USD | |
| VT | XLV | USD | |
| VY | XLV | USD | |
| X1 | XLVRUB | USD | |
| X2 | XLVRUB | USD | |
| X2 | XLVUSD | USD | |
| X9 | XLV | USD | |
| X9 | XLVUSD | USD | |
| XA | XLVUSD | USD | |
| XA | XLVRUB | USD | |
| XA | XLVGBP | USD | |
| XA | XLV | USD | |
| XB | XLVUSD | USD | |
| XE | XLVUSD | USD | |
| XE | XLVRUB | USD | |
| XE | XLVGBP | USD | |
| XE | XLV | USD | |
| XF | XLV | USD | |
| XF | XLVGBP | USD | |
| XF | XLVRUB | USD | |
| XF | XLVUSD | USD | |
| XG | XLVUSD | USD | |
| XG | XLVRUB | USD | |
| XG | XLVGBP | USD | |
| XG | XLV | USD | |
| XH | XLV | USD | |
| XH | XLVGBP | USD | |
| XH | XLVRUB | USD | |
| XH | XLVUSD | USD | |
| XJ | XLVUSD | USD | |
| XJ | XLVRUB | USD | |
| XJ | XLVGBP | USD | |
| XJ | XLV | USD | |
| XL | XLV | USD | |
| XL | XLVGBP | USD | |
| XL | XLVRUB | USD | |
| XL | XLVUSD | USD | |
| XO | XLVUSD | USD | |
| XO | XLVRUB | USD | |
| XO | XLVGBP | USD | |
| XO | XLV | USD | |
| XQ | XLVUSD | USD | |
| XQ | XLVRUB | USD | |
| XQ | XLVGBP | USD | |
| XQ | XLV | USD | |
| XS | XLV | USD | |
| XS | XLVGBP | USD | |
| XS | XLVRUB | USD | |
| XS | XLVUSD | USD | |
| XT | XLVRUB | USD | |
| XU | XLV | USD | |
| XU | XLVGBP | USD | |
| XU | XLVRUB | USD | |
| XU | XLVUSD | USD | |
| XV | XLVUSD | USD | |
| XV | XLVRUB | USD | |
| XV | XLVGBP | USD | |
| XV | XLV | USD | |
| XW | XLV | USD | |
| XW | XLVGBP | USD | |
| XW | XLVRUB | USD | |
| XW | XLVUSD | USD | |
| XX | XLVUSD | USD | |
| XX | XLVRUB | USD | |
| XX | XLVGBP | USD | |
| XX | XLV | USD | |
| XZ | XLV | USD | |
| XZ | XLVGBP | USD | |
| XZ | XLVRUB | USD | |
| XZ | XLVUSD | USD | |
For serious comparison — full data holdings, percentiles, advanced risk, tilt, flows
Full holdings
As of 2026-08-18 · the fund's own published holdings.
| # | Company | Weight |
|---|---|---|
| 1 | ELI LILLY + CO | 16.2% |
| 2 | JOHNSON + JOHNSON | 10.7% |
| 3 | ABBVIE INC | 7.7% |
| 4 | UNITEDHEALTH GROUP INC | 6.5% |
| 5 | MERCK + CO. INC. | 5.3% |
| 6 | AMGEN INC | 3.4% |
| 7 | THERMO FISHER SCIENTIFIC INC | 3.3% |
| 8 | ABBOTT LABORATORIES | 2.8% |
| 9 | GILEAD SCIENCES INC | 2.7% |
| 10 | INTUITIVE SURGICAL INC | 2.6% |
| 11 | PFIZER INC | 2.3% |
| 12 | VERTEX PHARMACEUTICALS INC | 2.3% |
| 13 | CVS HEALTH CORP | 2.2% |
| 14 | DANAHER CORP | 2.1% |
| 15 | BRISTOL MYERS SQUIBB CO | 2.0% |
| 16 | STRYKER CORP | 1.9% |
| 17 | MEDTRONIC PLC | 1.8% |
| 18 | MCKESSON CORP | 1.6% |
| 19 | ELEVANCE HEALTH INC | 1.5% |
| 20 | THE CIGNA GROUP | 1.3% |
| 21 | BOSTON SCIENTIFIC CORP | 1.1% |
| 22 | REGENERON PHARMACEUTICALS | 1.1% |
| 23 | HCA HEALTHCARE INC | 1.1% |
| 24 | CENCORA INC | 1.0% |
| 25 | CARDINAL HEALTH INC | 0.9% |
| 26 | EDWARDS LIFESCIENCES CORP | 0.9% |
| 27 | HUMANA INC | 0.8% |
| 28 | IDEXX LABORATORIES INC | 0.8% |
| 29 | BECTON DICKINSON AND CO | 0.7% |
| 30 | WATERS CORP | 0.6% |
| 31 | AGILENT TECHNOLOGIES INC | 0.6% |
| 32 | IQVIA HOLDINGS INC | 0.6% |
| 33 | RESMED INC | 0.5% |
| 34 | ZOETIS INC | 0.5% |
| 35 | CENTENE CORP | 0.5% |
| 36 | BIOGEN INC | 0.5% |
| 37 | GE HEALTHCARE TECHNOLOGY | 0.5% |
| 38 | MODERNA INC | 0.5% |
| 39 | VEEVA SYSTEMS INC CLASS A | 0.5% |
| 40 | DEXCOM INC | 0.5% |
| 41 | METTLER TOLEDO INTERNATIONAL | 0.4% |
| 42 | WEST PHARMACEUTICAL SERVICES | 0.4% |
| 43 | QUEST DIAGNOSTICS INC | 0.4% |
| 44 | LABCORP HOLDINGS INC | 0.4% |
| 45 | STERIS PLC | 0.4% |
| 46 | VIATRIS INC | 0.3% |
| 47 | INCYTE CORP | 0.3% |
| 48 | ZIMMER BIOMET HOLDINGS INC | 0.3% |
| 49 | COOPER COS INC/THE | 0.2% |
| 50 | REVVITY INC | 0.2% |
| 51 | ALIGN TECHNOLOGY INC | 0.2% |
| 52 | BAXTER INTERNATIONAL INC | 0.2% |
| 53 | SOLVENTUM CORP | 0.2% |
| 54 | CHARLES RIVER LABORATORIES | 0.2% |
| 55 | BIO TECHNE CORP | 0.2% |
| 56 | INSULET CORP | 0.2% |
| 57 | SSI US GOV MONEY MARKET CLASS | 0.2% |
| 58 | UNIVERSAL HEALTH SERVICES B | 0.1% |
| 59 | HENRY SCHEIN INC | 0.1% |
| 60 | DAVITA INC | 0.1% |
| 61 | XAV HEALTH CARE SEP26 | 0.0% |
| 62 | CONTRA HOLOGIC INCORPO | 0.0% |
| 63 | US DOLLAR | 0.0% |
How it ranks vs peers
Versus the Equity (stocks) · Other · USD ETFs we track.
Advanced risk
Concentration depth
Roughly 63 companies are held, but the largest names carry most of the weight — so it behaves like ~17 equal-sized positions.
Tilt vs a world tracker
Percentage points over / under a broad world-equity tracker (not a licensed benchmark).
Similar funds
We found 6 funds that do much the same job as this one. To pick them we matched this fund's asset class and region, then show how close each match is below.
| State Street® Health Care Select Sector SPDR® ETFSPDRYou're viewing | State Street® Technology Select Sector SPDR® ETFSPDRBroader match | Schwab International Equity ETFSchwabBroader match | State Street® Financial Select Sector SPDR® ETFSPDRBroader match | State Street® SPDR® S&P® 500 GBP Hdg UCITS ETF (Dist)SPDRBroader match | State Street® SPDR® S&P® 500 MXN Hdg UCITS ETF (Acc)SPDRBroader match | State Street® Energy Select Sector SPDR® ETFSPDRBroader match | |
|---|---|---|---|---|---|---|---|
| Why it's similar | This is the fund on this page. | StocksUnknownPhysical Tracks a different index in the same category. | StocksUnknownPhysicalCheaper fee Tracks a different index in the same category. | StocksUnknownPhysical Tracks a different index in the same category. | StocksPhysicalCheaper fee Tracks a different index in the same category. | StocksPhysicalCheaper fee Tracks a different index in the same category. | StocksUnknownPhysical Tracks a different index in the same category. |
| Index tracked | Health Care Select Sector Index | Technology Select Sector Index | FTSE Developed ex US Index | Financial Select Sector Index | ® ® S&p® 500 Hdg | ® ® S&p® 500 Mxn Hdg | Energy Select Sector Index |
| Yearly fee (TER) | 0.08% | 0.08% | 0.03% | 0.08% | 0.05% | 0.05% | 0.08% |
| All-in cost | 0.00% | 0.00% | 0.00% | 0.00% | 0.06% | 0.06% | 0.00% |
| Fund size | €37.3B | €106.4B | €56.1B | €49.2B | €38.1B | €37.9B | €35.8B |
| Domicile | United States | United States | United States | United States | Ireland | Ireland | United States |
| Replication | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) |
| 3-yr return p.a. | +8.3% | +31.3% | +13.9% | +19.4% | +12.7% | ||
| 5-yr return p.a. | +4.6% | +19.6% | +6.7% | +9.1% | +22.6% | ||
| # holdings | 63 | 76 | 1,494 | 80 | 505 | 505 | 24 |
The fund on this page stays pinned on the left — scroll or use ‹ › to compare it against each one.
Open the full comparison tool →New to ETFs? Start with the basics →
Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.